Universities and entrepreneurs are continually developing new innovations in the world of medical devices and diagnostics, but the 2008 economic crash, investor consolidation, and increased investor wariness have made funding for those ideas much harder to secure. Even before 2008, traditional venture funding for these projects was deteriorating, and purse strings have remained somewhat tight ever since.
Device and diagnostic organizations that can demonstrate real value, improve the existing standards of care, or prove that they can reduce healthcare spending are still drawing investor attention. However, even these companies have had to be creative about where they turn for funding.
This presentation will explore what types of medical device and diagnostic startups are attracting venture funding and what investors are looking for now.
- Paul Hadden, Principal, Healthcare Royalty Partners
- Mark Johnson, Senior Director of Surgical Services and Medical Device Evaluation, MPI Research
As our population ages and the demand for improved healthcare grows, medical device and diagnostic research companies are becoming more important than ever. In order to meet these demands, increased funding in early stage innovations and product development is needed.
Mark Johnson, MS
Senior Director of Surgical Services and Medical Device Evaluation